Hopital Uni Ire Dupuytren; Hematologie
About Hopital Uni Ire Dupuytren; Hematologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Hospices Civils de Lyon
2
Clinical Trials at Hopital Uni Ire Dupuytren; Hematologie
During the past decade, Hopital Uni Ire Dupuytren; Hematologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
2013-11-04
2018-10-08
Completed
979
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
2017-11-16
2024-05-31
Active, not recruiting
1,000
Transplantation After Complete Response In Patients With T-cell Lymphoma
2022-08-01
2028-04-01
Recruiting
204
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Uni Ire Dupuytren; Hematologie"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "The Lymphoma Academic Research Organisation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hopital Uni Ire Dupuytren; Hematologie
According to Clinical.Site data, the most researched conditions in "Hopital Uni Ire Dupuytren; Hematologie" are
"B-cell Lymphoma" (1 trials), "Burkitt Lymphoma (BL))" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B Lymphoma (DLBCL)" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hopital Uni Ire Dupuytren; Hematologie" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Uni Ire Dupuytren; Hematologie
Most popular intervention types in "Hopital Uni Ire Dupuytren; Hematologie" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "Cyclophosphamide" (2 trials), "Bendamustine" (1 trials), "Bevacizumab" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Uni Ire Dupuytren; Hematologie
The vast majority of trials in "Hopital Uni Ire Dupuytren; Hematologie" are
6 trials for "All" genders.
Clinical Trials Status at Hopital Uni Ire Dupuytren; Hematologie
Currently, there are NaN active trials in "Hopital Uni Ire Dupuytren; Hematologie".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hopital Uni Ire Dupuytren; Hematologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Uni Ire Dupuytren; Hematologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".